ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 118 filers reported holding ANAPTYSBIO INC in Q4 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $403 | -100.0% | 13,013 | -71.7% | 0.01% | -40.0% |
| Q2 2022 | $932,000 | +305.2% | 45,932 | +591.4% | 0.01% | +900.0% |
| Q4 2021 | $230,000 | -73.3% | 6,643 | -79.1% | 0.00% | -80.0% |
| Q3 2021 | $860,000 | -61.7% | 31,725 | -63.4% | 0.01% | -76.2% |
| Q2 2021 | $2,248,000 | +571.0% | 86,715 | +281.2% | 0.02% | +110.0% |
| Q3 2020 | $335,000 | +7.0% | 22,745 | +61.9% | 0.01% | +11.1% |
| Q2 2020 | $313,000 | – | 14,048 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |